Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 34.05
-0.30 (-0.87%)
At close: Feb 11, 2026
Sofiva Genomics Market Cap
Sofiva Genomics has a market cap or net worth of 735.26 million as of February 13, 2026. Its market cap has decreased by -14.66% in one year.
Market Cap
735.26M
Enterprise Value
663.38M
Revenue
393.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.05
Market Cap Chart
Since January 5, 2017, Sofiva Genomics's market cap has decreased from 1.70B to 735.26M, a decrease of -56.72%. That is a compound annual growth rate of -8.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 735.26M | 12.94% |
| Dec 31, 2025 | 651.04M | -24.53% |
| Dec 31, 2024 | 862.66M | -1.51% |
| Dec 29, 2023 | 875.86M | 11.72% |
| Dec 30, 2022 | 784.00M | -24.75% |
| Dec 30, 2021 | 1.04B | -4.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| Radiant Innovation | 845.23M |
| PlexBio | 837.49M |
| SynCore Biotechnology Co.,Ltd | 771.87M |
| BioLASCO Taiwan | 761.96M |